DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Halozyme Therapeutics
HALO
Teradata Corp
TDC
Cars.com
CARS
Collegium Pharmaceutical
COLL
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 12.95%629.36M | 25.43%715.35M | -25.49%500M | -12.16%2.04B | 19.76%532.22M | -0.38%557.22M | 21.16%570.33M | 28.58%671.05M | -34.77%2.32B | -43.38%444.4M |
Operating revenue | 12.91%625.93M | 23.30%699.62M | -25.79%496.39M | 34.60%2.63B | 1,207.54%1.13B | -0.32%554.34M | 21.22%567.39M | 28.87%668.86M | -50.73%1.95B | -92.78%86.61M |
Cost of revenue | 33.33%390.37M | 14.44%363.43M | 15.47%305.23M | 17.47%1.19B | 23.73%316.97M | 27.46%292.78M | 35.04%317.58M | -9.91%264.32M | -28.84%1.01B | -28.05%256.17M |
Gross profit | -9.62%238.99M | 39.24%351.93M | -52.11%194.78M | -35.16%847.47M | 14.36%215.25M | -19.78%264.44M | 7.29%252.75M | 78.00%406.73M | -38.73%1.31B | -56.10%188.23M |
Operating expense | 5.27%144.89M | 21.57%218.06M | -58.92%150.25M | -20.19%493.43M | -7.54%102.4M | -3.81%137.63M | 254.60%179.37M | 3,377.12%365.73M | -20.11%618.27M | -43.11%110.75M |
Selling and administrative expenses | 7.89%76.32M | -8.84%53.47M | -17.81%52.36M | -29.60%238.08M | -13.79%44.99M | -3.19%70.74M | -39.76%58.65M | -44.87%63.71M | -26.68%338.17M | -50.83%52.19M |
-Selling and marketing expense | 9.84%5.09M | -2.38%5.45M | 13.27%3.67M | -62.30%17.63M | 11.44%4.18M | -39.06%4.63M | -57.12%5.58M | -85.53%3.24M | 4.37%46.76M | -77.36%3.75M |
-General and administrative expense | 7.75%71.23M | -9.52%48.02M | -19.48%48.69M | -24.35%220.45M | -15.75%40.81M | 0.97%66.1M | -37.09%53.07M | -35.09%60.47M | -30.02%291.41M | -45.93%48.44M |
Other taxes | 4.91%18.73M | 0.47%18.85M | 2.75%22.2M | -17.95%76.01M | 7.37%17.79M | -14.01%17.85M | -8.40%18.76M | -37.97%21.61M | -22.22%92.64M | -43.39%16.57M |
Other operating expenses | 1.63%49.85M | 42.94%145.74M | -73.01%75.7M | -4.33%179.34M | -5.64%39.62M | -0.43%49.05M | 251.58%101.96M | 273.59%280.42M | -3.15%187.46M | -29.13%41.99M |
Operating profit | -25.79%94.1M | 82.44%133.87M | 8.59%44.53M | -48.59%354.04M | 45.65%112.85M | -32.04%126.81M | -60.33%73.38M | -82.89%41M | -49.34%688.69M | -66.90%77.48M |
Net non-operating interest income expense | ||||||||||
Other net income (expense) | -1,670.00%-177K | 96.30%-17K | 77.49%-643K | -626.81%-170.41M | -1,613.65%-167.08M | 99.10%-10K | 93.83%-460K | 44.38%-2.86M | -15,325.00%-23.45M | -243,850.00%-9.75M |
Special income (charges) | -1,670.00%-177K | 96.30%-17K | 77.49%-643K | -626.81%-170.41M | -1,613.65%-167.08M | 99.10%-10K | 93.83%-460K | 44.38%-2.86M | -15,325.00%-23.45M | -243,850.00%-9.75M |
-Less:Restructuring and merger&acquisition | 1,670.00%177K | -96.30%17K | -77.49%643K | -59.37%7.64M | -15.49%4.31M | -99.10%10K | -93.83%460K | -44.38%2.86M | 11,949.36%18.8M | --5.1M |
-Less:Other special charges | ---- | ---- | ---- | 3,401.18%162.77M | ---- | ---- | ---- | ---- | 116,325.00%4.65M | ---- |
Income before tax | -25.92%93.93M | 83.57%133.85M | 15.04%43.88M | -72.40%183.63M | -180.07%-54.23M | -31.64%126.8M | -58.93%72.92M | -83.73%38.15M | -51.06%665.25M | -71.07%67.73M |
Income tax | -27.62%24.56M | 142.69%35.6M | -41.11%4.58M | -79.46%38.98M | -157.74%-17.39M | -32.60%33.93M | -69.67%14.67M | -87.25%7.77M | -46.66%189.74M | -50.66%30.11M |
Net income | -25.31%69.37M | 68.68%98.26M | 29.40%39.31M | -69.58%144.66M | -197.94%-36.84M | -31.28%92.87M | -54.90%58.25M | -82.50%30.38M | -52.61%475.51M | -78.27%37.62M |
Net income continuous Operations | -25.31%69.37M | 68.68%98.26M | 29.40%39.31M | -69.58%144.66M | -197.94%-36.84M | -31.28%92.87M | -54.90%58.25M | -82.50%30.38M | -52.61%475.51M | -78.27%37.62M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -25.31%69.37M | 68.68%98.26M | 29.40%39.31M | -69.58%144.66M | -197.94%-36.84M | -31.28%92.87M | -54.90%58.25M | -82.50%30.38M | -52.61%475.51M | -78.27%37.62M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -25.31%69.37M | 68.68%98.26M | 29.40%39.31M | -69.58%144.66M | -197.94%-36.84M | -31.28%92.87M | -54.90%58.25M | -82.50%30.38M | -52.61%475.51M | -78.27%37.62M |
Basic earnings per share | -26.88%1.36 | 64.96%1.93 | 27.87%0.78 | -67.75%2.89 | -198.67%-0.74 | -28.19%1.86 | -50.84%1.17 | -80.39%0.61 | -43.04%8.96 | -74.75%0.75 |
Diluted earnings per share | -26.55%1.3 | 66.67%1.85 | 29.82%0.74 | -67.76%2.74 | -204.23%-0.74 | -28.05%1.77 | -51.32%1.11 | -80.61%0.57 | -42.84%8.5 | -74.55%0.71 |
Dividend per share | 50.00%0.3 | 0.00%0.2 | 0.00%0.2 | 0.00%0.8 | 0.00%0.2 | 0.00%0.2 | 0.00%0.2 | 0.00%0.2 | 0.00%0.8 | 0.00%0.2 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |